FAHFAs, which possess antiinflammatory and insulin-sensitizing properties (21), were lower in individuals with obesity (e.g., FAHFA 18:1/18:0 and FAHFA 16:0/22:3) (Figure 7, F and G). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.